These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6332862)

  • 21. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer.
    Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U
    Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of passive antilisterial immunity and change of Lyt phenotype following in vitro stimulation of murine lymphoid cells from immune donors.
    Barry RA; Hinrichs DJ
    Clin Invest Med; 1984; 7(4):303-9. PubMed ID: 6442653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF; de Paus RA; Kluin-Nelemans HC; Kluin PM; van Bergen CA; Munro AJ; Hale G; Willemze R; Falkenburg JH
    Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isolation of monoclonal antibodies to antigen Lyt-3.2].
    Filatov AV; Chervonskiĭ AV; Brondz BD
    Biull Eksp Biol Med; 1984 Aug; 98(8):223-6. PubMed ID: 6380619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crossreactivity of anti Lyt-2.2 monoclonal antibody with some Lyt-2.2-negative mouse strains.
    Kuśnierczyk P; Opolski A; Seshadri M; Kisielow P
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):511-7. PubMed ID: 3501944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J; Hu P; Khawli LA; Epstein AL
    Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive ATS. V. Analysis of the effect of anti-thymocyte serum on T lymphocyte subsets.
    Zimmerman B; Swain SL; Dutton RW
    J Immunol; 1982 Aug; 129(2):515-20. PubMed ID: 6211488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
    Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level.
    MacDonald HR; Thiernesse N; Cerottini JC
    J Immunol; 1981 May; 126(5):1671-5. PubMed ID: 6452474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Con A-induced TCGF-reactivity is selectively acquired by Lyt-2-positive T cell precursors.
    Gullberg M; Larsson EL
    J Immunol; 1983 Jul; 131(1):19-22. PubMed ID: 6602829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful islet allografting requires depletion of both Lyt-2+ and L3T4+ cells.
    Yamamoto H; Monden M; Gotoh M; Ichikawa T; Kubota N; Kawai M; Mori T; Sakurai M; Uenaka A; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2707-8. PubMed ID: 2495676
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmonella abortusovis infection in susceptible BALB/cby mice: importance of Lyt-2+ and L3T4+ T cells in acquired immunity and granuloma formation.
    Guilloteau L; Buzoni-Gatel D; Bernard F; Lantier I; Lantier F
    Microb Pathog; 1993 Jan; 14(1):45-55. PubMed ID: 8321117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmented antitumor effects of radiation therapy by 4-1BB antibody (BMS-469492) treatment.
    Shi W; Siemann DW
    Anticancer Res; 2006; 26(5A):3445-53. PubMed ID: 17094465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel lymphocyte function-associated antigen (LFA-1): cellular distribution, quantitative expression, and structure.
    Kürzinger K; Reynolds T; Germain RN; Davignon D; Martz E; Springer TA
    J Immunol; 1981 Aug; 127(2):596-602. PubMed ID: 6788846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.
    Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.